| 000 | 01358nam a22003017i 4500 | ||
|---|---|---|---|
| 005 | 20251030135850.0 | ||
| 007 | t| | ||
| 008 | 230206s2018 dcu||||| |||| 00| 0 spa d | ||
| 020 | _a9781582122960 | ||
| 040 |
_aCO-ViULL _erda _bspa |
||
| 041 | _heng | ||
| 082 | 0 |
_223 _a615.1 _bT837t |
|
| 100 | 1 |
_aTrissel, Lawrence A. _9160216, _eautor. _4aut |
|
| 245 | 1 | 0 |
_aTrissel´s : _bStability of compounded Formulations. |
| 250 | _a6. | ||
| 264 | 1 |
_aWashington, District of Columbia : _bAmerican Pharmacists Association APha, _c2018. |
|
| 300 |
_a685 páginas : _b: tables. |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_asin mediación _bn _2rdamedia |
||
| 338 |
_avolumen _bnc _2rdacarrier |
||
| 500 | _aContents and references. | ||
| 520 | _aBased on data published over the past 60 years, the reference summarizes specific formulations and stability studies. It helps readers (a) determine whether formulated compounds will be stable for the anticipated duration of use, (b) properly store and repackage compounded formulations and some commercial products, (c) formulate in accordance with documented standards, and (d) counsel patients on the use and storage of compounded medications. | ||
| 650 | 0 |
_aPharmacy _9160047. |
|
| 650 | 0 |
_aMedicine _9160217. |
|
| 700 | 1 |
_aAshworth, Lisa D. _9160218. |
|
| 700 | 1 |
_aAshworth, Jay. _9160219. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c47354 _d47354 |
||